Be part of our team
The Senior Manager, Business Insights & Strategy will help build Tubulis’ enterprise strategy and insights capability, turning competitive intelligence, market context, and external signals into decision-ready frameworks and recommendations that shape business development, portfolio, and program strategy. Reporting to the Senior Director of Business Development, this role will function as an internal strategy and analytics partner to Clinical Development, R&D, and Commercial, translating external intelligence into clear implications, options and recommendations.
In this pre-commercial stage, you will build frameworks and capabilities that guide portfolio choices, resource allocation, and business development strategy (e.g., which assets to in-license, how to position programs for out-licensing). This is an opportunity to shape strategic direction at a clinical-stage biotech with direct exposure to executive leadership and Board-level decision-making, while partnering closely with Business Development to inform in-licensing priorities and deal strategy.
This position can be based in Boston, MA or remotely in MA, PA, NY, RI, NJ, NC, MD or FL.
Why us?
At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.
- Impact that matters: Contribute to breakthrough therapies.
- Global mindset: Work in an international, diverse team.
- Grow & thrive: Develop your career in a supportive, fast-moving environment.
- Innovation every day: Push boundaries with cutting-edge science.
At Tubulis, your ideas matter, your growth matters—and together, we make a difference.
About us
Tubulis is a clinical stage biotech company that generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models. We recently closed on a Series C fundraising round totaling €344M (US $401M).
The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and ADCs. With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.
